John Wiley and Sons: Life Expectancy and Healthcare Costs for Patients With Rheumatoid Arthritis
December 09, 2020
December 09, 2020
HOBOKEN, New Jersey, Dec. 9 (TNSJou) -- John Wiley and Sons issued the following news release:
A new study published in Arthritis & Rheumatology suggests that recent advances in the treatment of rheumatoid arthritis have prolonged patients' lives but also increased healthcare costs.
For the study, investigators examined medical claims data from the National Health Insurance of Taiwan, identifying 29,352 new cases of rheumatoid arthritis from 2003-2016.
. . .
A new study published in Arthritis & Rheumatology suggests that recent advances in the treatment of rheumatoid arthritis have prolonged patients' lives but also increased healthcare costs.
For the study, investigators examined medical claims data from the National Health Insurance of Taiwan, identifying 29,352 new cases of rheumatoid arthritis from 2003-2016.
. . .